LeafLine Labs blamed a temporary testing disruption, but worried patients say they have come to rely on medical marijuana for the treatment of severe illnesses and pain.
A distribution glitch at one of Minnesota’s two medical marijuana providers has left some patients with little or no supply left for treatment of conditions such as chronic pain, epileptic seizures and Tourette syndrome.
One patient, Katie Kennedy, said she called LeafLine Labs on Monday because she had no cannabis left for the management of her chronic pain and only a two-day supply left for the management of her son’s Tourette and autism.
She said a LeafLine representative replied that it had none available until Friday, though it later provided a small quantity to get her son through the week.
Read More at StarTribune.com
SIGN UP FOR FREE POST ALERTS!
